MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-19-0033135
Cellcure Cancer Centre Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹445.56 Cr
▲ 33% YoY
Net profit · FY 2026
₹15.57 Cr
Net margin 3.5%
EBITDA · FY 2026
₹31.35 Cr
EBITDA margin 7%
Authorised capital
₹3.57 Cr
Registered with MCA
Paid-up capital
₹1.88 Cr
Issued & subscribed
Satisfied charges
₹2.3 Cr
No open charges
Company age
9 yrs
Est. 2017
Employees · EPFO
354
Provident fund records
About Cellcure Cancer Centre Private Limited
Data last updated:
Cellcure Cancer Centre Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 25 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC301138. Its GSTIN is 27AAHCC2532P2ZC (Maharashtra). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹3.57 Cr and a paid-up capital of ₹1.88 Cr. It is led by directors including Vashista Pankaj Maniar and Bhavin Ashokbhai Shah.
Its last annual general meeting (AGM) was held on 26 August 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2026, the company reported a revenue of ₹445.56 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹15.57 Cr (net margin 3.5%) and EBITDA of ₹31.35 Cr (EBITDA margin 7%). Revenue has grown at a compounded annual rate (CAGR) of 61% over three years and 57% over five years.
The company has about 354 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: MOC Cancer Care Foundation and MOC India. As per MCA filings, the company has satisfied charges of ₹2.3 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹201.45 Cr; the latest was in March 2025. The company has 17 MSME Form 1 returns on record between 2019 and 2024, listing 302 overdue payments to 32 micro and small suppliers.
Cellcure Cancer Centre Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-19-0033135). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mocindia.co.in.
Company details
CIN U74999MH2017PTC301138
Registration Number 301138
Incorporation Date 25 October 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 August 2026
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-19-0033135
Key People
Vashista Pankaj Maniar Director Bhavin Ashokbhai Shah Director Ashish Anand Joshi Director Recognitions & Rankings of Cellcure Cancer Centre
Contact details
Cellcure Cancer Centre Private Limited's registered office is in Mumbai, Maharashtra. Its website is mocindia.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1st & 2nd Floor Shree Saraswati Apartments, Chsl Opposite Bhagwati Hospital S.V. Road, Mumbai, Maharashtra, India – 400092
- IndustryHealthcare, Hospitals
To see the full contact details of Cellcure Cancer Centre Private Limited, buy the company report.
Comprehensive company report
Cellcure Cancer Centre Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Cellcure Cancer Centre operates two associated brands: MOC Cancer Care Foundation and MOC India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Oncology and hematology services are delivered via clinic chains. | mocindia.co.in | |
| Cancer care foundation offering patient support and research funding in India. | mocfoundation.com |
Business activity
The main business activity of Cellcure Cancer Centre is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Cellcure Cancer Centre Private Limited, buy the company report.
Financials of Cellcure Cancer Centre Private Limited
FY 2026 filings availableCellcure Cancer Centre Private Limited reported revenue of ₹445.56 Cr (up 33% YoY) for FY 2026.
Revenue · FY 2026
₹445.56 Cr ▲ 33%
Net profit · FY 2026
₹15.57 Cr margin 3.5%
EBITDA · FY 2026
₹31.35 Cr margin 7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 33%
3 years · compounded
▲ 61%
5 years · compounded
▲ 57%
EBITDA CAGR growth
1 year
▲ 211%
3 years · compounded
▲ 128%
5 years · compounded
▲ 24%
Revenue has grown at a compounded annual rate (CAGR) of 57% over five years, including 33% growth in the latest year. EBITDA rose 211% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹445.56 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹31.35 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.57 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7% | ||||
| Net Profit Margin | 3.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cellcure Cancer Centre Private Limited, buy the company report.
Board of directors of Cellcure Cancer Centre Private Limited
Cellcure Cancer Centre has 7 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vashista Pankaj Maniar Also directs: Moc Cancer Care Foundation | Director | 25 Oct 2017 | 9 Years 0 Months | Current |
| Bhavin Ashokbhai Shah | Director | 24 May 2024 | 2 Years 5 Months | Current |
| Ashish Anand Joshi Also directs: Moc Cancer Care Foundation | Director | 25 Oct 2017 | 9 Years 0 Months | Current |
| Kshitij Chandrakant Joshi | Director | 25 Oct 2017 | 9 Years 0 Months | Current |
| Preetam Baban Kalaskar | Director | 25 Oct 2017 | 9 Years 0 Months | Current |
| Visalakshi Chandramouli Also directs: Sakar Healthcare Limited, Brinton Pharmaceuticals Limited, Linux Laboratories Private Limited and 4 more | Additional Director | 29 Nov 2025 | 0 Years 11 Months | Current |
Showing 6 of 7 current directors. View all directors
Auditor
Cellcure Cancer Centre Private Limited is audited by KKC & Associates LLP for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KKC & Associates LLP | FY 2026 | 105146W/W100621 |
Shareholding
The shareholding of Cellcure Cancer Centre Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cellcure Cancer Centre Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹2.3 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Nov 2022 | 100651004 | Hdfc Bank Limited | ₹2.3 Cr | Satisfied |
To see the full charge records of Cellcure Cancer Centre Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Cellcure Cancer Centre Private Limited has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹201.45 Cr; the latest was in March 2025.
Total deals
8
Funding rounds
4
Secondary share transfers
4
Disclosed funding
₹201.45 Cr
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2025 | Funding round · Series B | ₹125 Cr | Investors: Elevation Capital (SAIF Partners) |
| Jun 2023 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Apr 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2023 | Funding round · Series A | ₹75 Cr | Investors: Tata Capital Healthcare Fund |
| Apr 2021 | Secondary share transfer | Undisclosed | Seller: 4 individuals |
To see the full deal history of Cellcure Cancer Centre Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Cellcure Cancer Centre Private Limited has 1 court case on record: 1 filed by Cellcure Cancer Centre. All case is pending.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed by the company against an individual | Pending |
To see the full case history of Cellcure Cancer Centre Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Cellcure Cancer Centre Private Limited has 17 MSME Form 1 returns on record between 2019 and 2024, listing 302 overdue payments to 32 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 32)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Novacare Healthcare Solutions Private Limited | |||
| Impact Design Cell | |||
| an individual supplier | |||
| P.B.P Enterprises Private Limited | |||
| Certaincure Pharma Private Limited |
To see the full MSME payment records of Cellcure Cancer Centre Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Cellcure Cancer Centre Private Limited has a workforce of 354 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
Employee count
354
Active EPFO establishments
1
Employee growth
33.58%
GST
Cellcure Cancer Centre has 4 GST registrations: 3 active and 1 cancelled or inactive.
Total GSTINs
4
Active
3
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCC2532P2ZC | Maharashtra | Active | 14 Jun 2022 |
| 24AAHCC2532P1ZJ | Gujarat | Active | 28 Apr 2025 |
| 07AAHCC2532P1ZF | Delhi | Active | 30 May 2025 |
To see the full GST registrations and return filing status of Cellcure Cancer Centre Private Limited, buy the company report.
Recent activity
Cellcure Cancer Centre Private Limited has 16 board changes on record since 2017: 9 appointments and 7 cessations. The latest: Chirag Chadha was appointed as Director on 01 Apr 2026.
AGM
Cellcure Cancer Centre Private Limited last Annual general meeting of members was held on 26 Aug 2026 as per latest MCA records.
Appointed
Chirag Chadha was appointed as Director.
Filing
Cellcure Cancer Centre Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
Appointed
Visalakshi Chandramouli was appointed as Additional Director.
Ceased
Mayank Khanduja ceased to be Additional Director.
Appointed
Mayank Khanduja was appointed as Director.
Charges
A charge registered on 15 Nov 2022 via Charge ID 100651004 with Hdfc Bank Limited was fully satisfied on 31 Jul 2024.
Appointed
Bhavin Ashokbhai Shah was appointed as Director.
Ceased
Bhavin Ashokbhai Shah ceased to be Additional Director.
Ceased
Vamesh Bhupendra Chovatia ceased to be Additional Director.
Appointed
Vamesh Bhupendra Chovatia was appointed as Director.
Charges
A charge with Hdfc Bank Limited of Rs. 2.30 Cr registered on 15 Nov 2022 with Charge ID 100651004 was modified on 31 Jan 2023.
10 earlier events are in the company report.
News
Frequently asked questions
Cellcure Cancer Centre is an active private limited company based in Mumbai, Maharashtra, India. The company works in hospitals, within the healthcare industry. It was incorporated on 25 October 2017 (9+ years old) and is registered under CIN U74999MH2017PTC301138.
Cellcure Cancer Centre has 7 current directors:
- Vashista Pankaj Maniar - Director
- Bhavin Ashokbhai Shah - Director
- Ashish Anand Joshi - Director
- Kshitij Chandrakant Joshi - Director
- Preetam Baban Kalaskar - Director
- Visalakshi Chandramouli - Additional Director
- Chirag Chadha - Director
The latest financial statements of Cellcure Cancer Centre on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 26 August 2026. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Cellcure Cancer Centre is 27AAHCC2532P2ZC, registered in Maharashtra. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 24AAHCC2532P1ZJ (Gujarat), 07AAHCC2532P1ZF (Delhi).
The CIN (Corporate Identification Number) of Cellcure Cancer Centre is U74999MH2017PTC301138. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cellcure Cancer Centre has 1 court case on record: 1 filed by the company. 1 is pending.
Cellcure Cancer Centre was incorporated on 25 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Cellcure Cancer Centre has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹201.45 Cr; the latest was in March 2025.
Chirag Chadha was appointed as Director on 01 Apr 2026. Visalakshi Chandramouli was appointed as Additional Director on 29 Nov 2025. Mayank Khanduja ceased to be Additional Director on 13 Mar 2025. Cellcure Cancer Centre has 16 board changes on record in total.
Yes, Cellcure Cancer Centre is registered as an MSME under Udyam registration (number: UDYAM-MH-19-0033135).
Cellcure Cancer Centre has 17 MSME Form 1 returns on record between 2019 and 2024, listing 302 overdue payments to 32 micro and small suppliers. The latest return was filed on 23 Apr 2024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages